Products for Calcification Medicine
CALCISCON AG
Incorporated
13.08.2013Headquarters
NidauSupport
Invented a unique calcification blood test, secured IP, developed and CE-marked scalable test kit, conducted clinical studies, now ready to go to market; estimated longer-term global market volume is 200 to 600 mCHF annually;
Additional potential for further calcification IVD tests plus devices and therapeutics goes into the billions. Already started working on these developments/products.
Want to become a leading company in calcification medicine.
News
Calciscon and consortium obtain €2 million Eurostars project (startupticker.ch)
Calciscon, Amsterdam University Medical Center, and Admesy to develop T50 test benchtop analyzer with EUR 2 million of Eurostars funding (venturelab.swiss)
Calciscon raises CHF 2.5M Series A to conquer the European market (startupticker.ch)
Calciscon raises CHF 2.5M Series A to commercialize the T50 Test to drive more efficient therapies for renal patients (venturelab.swiss)
Tech Tour reveals 13 World Tour finalists from Switzerland (startupticker.ch)
Ventures for the Virtual Venture Day revealed (startupticker.ch)
Calciscon completes over-subscribed pre-series A financing (startupticker.ch)
Calciscon raises CHF 600K in pre-Series A financing round to initiate sales of T50 Calcification Propensity test (venturelab.swiss)
The Alpine High-tech Venture Forum: Startup Registration Open (startupticker.ch)
Three Swiss start-ups in the Top 25 European Venture Contest Award winners (startupticker.ch)
IMD announces Start-up Competition Winners (startupticker.ch)
Volkswirtschaftsstiftung: 400‘000 Franken für Jungfirmen (startupticker.ch)
Gewinner des Awards der W. A. de Vigier Stiftung: Calcisco (startupticker.ch)
Eight start-ups selected for the Swiss Venture Day in Zurich (startupticker.ch)
TwingTec and CALCISCO win the CHF 130’000 final kick (startupticker.ch)
Videos and Presentations
Video 1